HomeCompareONVO vs EQR

ONVO vs EQR: Dividend Comparison 2026

ONVO yields 98.04% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ONVO wins by $3.55M in total portfolio value
10 years
ONVO
ONVO
● Live price
98.04%
Share price
$2.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.59M
Annual income
$1,195,548.96
Full ONVO calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — ONVO vs EQR

📍 ONVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodONVOEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ONVO + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ONVO pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ONVO
Annual income on $10K today (after 15% tax)
$8,333.33/yr
After 10yr DRIP, annual income (after tax)
$1,016,216.62/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, ONVO beats the other by $1,011,562.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ONVO + EQR for your $10,000?

ONVO: 50%EQR: 50%
100% EQR50/50100% ONVO
Portfolio after 10yr
$1.82M
Annual income
$600,512.28/yr
Blended yield
32.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

ONVO
Analyst Ratings
3
Buy
5
Hold
Consensus: Hold
Altman Z
-69.6
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ONVO buys
0
EQR buys
0
No recent congressional trades found for ONVO or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricONVOEQR
Forward yield98.04%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$3.59M$47.8K
Annual income after 10y$1,195,548.96$5,475.61
Total dividends collected$3.20M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: ONVO vs EQR ($10,000, DRIP)

YearONVO PortfolioONVO Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$20,504$9,803.92$11,380$679.82+$9.1KONVO
2$40,726$18,786.81$13,014$837.25+$27.7KONVO
3$78,451$34,874.18$14,961$1,036.20+$63.5KONVO
4$146,726$62,783.72$17,297$1,289.22+$129.4KONVO
5$266,739$109,741.95$20,121$1,613.15+$246.6KONVO
6$471,863$186,452.24$23,561$2,030.84+$448.3KONVO
7$813,151$308,257.14$27,783$2,573.54+$785.4KONVO
8$1,366,531$496,460.13$33,013$3,284.39+$1.33MONVO
9$2,241,927$779,738.88$39,547$4,223.51+$2.20MONVO
10$3,594,411$1,195,548.96$47,791$5,475.61+$3.55MONVO

ONVO vs EQR: Complete Analysis 2026

ONVOStock

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Full ONVO Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this ONVO vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ONVO vs SCHDONVO vs JEPIONVO vs OONVO vs KOONVO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.